(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ANGIOFLUOR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ANGIOFLUOR

ST13

US500000076354442

Class

5

Filing

76354442

Registration

2628244

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

03/01/2023

Trademark type

Word

Nice classes

5

Filing date

01/02/2002

Registration date

10/01/2002

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/01/2023

Last transaction

03/01/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

01/01/1991

First use in commerce

01/01/1991

Drawing code

1

Owner type

03

Owner location

Rosenberg, TX

Examiner

BROWN, BRIAN

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Ocusoft, Inc.
Ocusoft, Inc.

Representatives

Usha Menon D'AMBROSIO & MENON, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Fluorescein sodium injection used for ophthalmic angiography and angioscopy

Publications

History of USPTO decisions and trademark events.

23 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/01/2023

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

03/01/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/01/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/27/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

08/09/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/01/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/28/2016

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/29/2012

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/29/2012

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/29/2012

E89R

TEAS SECTION 8 & 9 RECEIVED

09/28/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/08/2011

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/05/2008

PLGL

ASSIGNED TO PARALEGAL

09/04/2008

E815

TEAS SECTION 8 & 15 RECEIVED

09/02/2008

CFIT

CASE FILE IN TICRS

06/27/2008

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/27/2003

R.PR

REGISTERED-PRINCIPAL REGISTER

10/01/2002

PUBO

PUBLISHED FOR OPPOSITION

07/09/2002

NPUB

NOTICE OF PUBLICATION

06/19/2002

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/03/2002

CNEA

EXAMINER'S AMENDMENT MAILED

03/26/2002

DOCK

ASSIGNED TO EXAMINER

03/20/2002

Continuous trademark protection

Get notified about every new filing that threatens ANGIOFLUOR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.